Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys-Reference-Cited by-同舟云学术

Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys

Published:2018-01-01 Issue:1 Volume:36 Page:50-58
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Engler Robert¹²,Routh Timothy L.²,Lucisano Joseph Y.²

Affiliation:

1. University of California, San Diego, School of Medicine, San Diego, CA

2. GlySens, Inc., San Diego, CA

Abstract

IN BRIEF A patient-centered approach to device design can provide important advantages in optimizing diabetes care technology for broadened adoption and improved adherence. Results from two surveys of people with diabetes and the parents of children with diabetes (n = 1,348) regarding continuous glucose monitoring (CGM) devices reveal the importance of the concept of “user burden” in patients’ and caregivers’ evaluations of the acceptability of available devices. Survey respondents’ strongly favorable reactions to a proposed 1-year, fully implanted CGM device with no skin-attached components further confirm that minimizing system obtrusiveness will likely be of significant value in reducing hurdles to CGM device use and adherence.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/36/1/50/501004/50.pdf

Reference30 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;DCCT Research Group;N Engl J Med,1993

2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview;Nathan;Diabetes Care,2014

3. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up;DCCT/EDIC Study Research Group;Diabetes Care,2016

4. Continuous glucose monitoring and intensive treatment of type 1 diabetes;JDRF Continuous Glucose Monitoring Study Group;N Engl J Med,2008

5. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes;Battelino;Diabetes Care,2011

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A long lifetime and highly sensitive wearable microneedle sensor for the continuous real-time monitoring of glucose in interstitial fluid;Biosensors and Bioelectronics;2024-01

2. A Narrative Review on Strategies for the Reversion of Prediabetes to Normoglycemia: Food Pyramid, Physical Activity, and Self-Monitoring Innovative Glucose Devices;Nutrients;2023-11-28

3. Association of Continuous Glucose Monitor Receipt and Diabetes Care Provider Type;Medical Care;2023-09-22

4. Current state of the art and future directions for implantable sensors in medical technology: Clinical needs and engineering challenges;APL Bioengineering;2023-09-01

5. Therapeutic Inertia and Delays in Insulin Intensification in Type 2 Diabetes: A Literature Review;Diabetes Spectrum;2023-06-23